🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/12/2015 6,04 6,23 6,04 6,20 +1,97% 3,15% 344.300
23/12/2015 5,99 6,17 5,95 6,08 +1,50% 3,67% 505.700
22/12/2015 6,08 6,15 5,83 5,99 -1,80% 5,26% 779.500
21/12/2015 6,10 6,15 5,82 6,10 +2,01% 5,41% 877.600
18/12/2015 6,12 6,31 5,95 5,98 -2,29% 5,88% 2.309.100
17/12/2015 5,73 6,28 5,64 6,12 +7,09% 11,17% 1.251.300
16/12/2015 5,64 5,74 5,46 5,72 +2,42% 4,96% 1.269.200
15/12/2015 5,75 5,94 5,50 5,58 -1,93% 7,65% 1.319.100
14/12/2015 5,65 5,73 5,48 5,69 +0,89% 4,42% 1.268.100
11/12/2015 5,67 5,80 5,60 5,64 -3,42% 3,53% 933.800
10/12/2015 5,95 5,97 5,80 5,84 -2,34% 2,91% 849.400
09/12/2015 6,15 6,20 5,96 5,98 -3,39% 3,90% 797.900
08/12/2015 6,10 6,45 6,05 6,19 -0,80% 6,56% 1.063.600
07/12/2015 5,86 6,40 5,65 6,24 +12,64% 12,80% 2.457.900
04/12/2015 5,47 5,58 5,42 5,54 +0,73% 2,93% 652.200
03/12/2015 5,97 5,97 5,46 5,50 -7,72% 8,63% 1.173.800
02/12/2015 6,17 6,22 5,93 5,96 -3,09% 4,70% 848.900
01/12/2015 6,38 6,40 5,99 6,15 -2,69% 6,43% 931.300
30/11/2015 6,35 6,38 6,05 6,32 +0,48% 5,20% 900.500
27/11/2015 6,06 6,33 6,02 6,29 +3,45% 5,12% 601.800
25/11/2015 5,83 6,13 5,82 6,08 +5,01% 5,32% 1.273.100
24/11/2015 5,56 5,89 5,40 5,79 +4,14% 8,81% 897.600
23/11/2015 5,38 5,65 5,28 5,56 +3,15% 6,88% 666.500
20/11/2015 5,46 5,46 5,30 5,39 -0,37% 2,93% 712.300
19/11/2015 5,56 5,61 5,36 5,41 -2,87% 4,51% 965.100
18/11/2015 5,47 5,61 5,42 5,57 +1,46% 3,38% 1.197.400
17/11/2015 5,92 5,92 5,38 5,49 -4,19% 9,12% 1.447.400
16/11/2015 5,98 6,14 5,66 5,73 +0,88% 8,03% 2.352.100
13/11/2015 5,50 5,76 5,42 5,68 +3,27% 6,18% 903.400
12/11/2015 5,71 5,82 5,46 5,50 -4,35% 6,30% 996.200